Literature DB >> 28536876

Design and one-pot synthesis of 2-thiazolylhydrazone derivatives as influenza neuraminidase inhibitors.

Keyang Yuan1, Mengwu Xiao1, Ying Tan1, Jiao Ye2, Yongle Xie1, Xiaoxiao Sun1, Aixi Hu3, Wenwen Lian4, Ailin Liu4.   

Abstract

Two series of novel 2-thiazolylhydrazone derivatives were designed and synthesized via one-pot reaction of benzaldehyde derivatives, [Formula: see text]-haloketones and thiosemicarbazide. The structures of compounds 1 and 2 were characterized by [Formula: see text] NMR and [Formula: see text] NMR, and compound 1g was further confirmed by X-ray crystallography. All of the target compounds were evaluated for their NA inhibitory activity against influenza viral neuraminidase (H1N1) in vitro, and the results showed that many compounds exhibited moderate to strong inhibitory activities against influenza viral neuraminidase (H1N1). Among them, compounds 1p, 1q and 2c showed the most potent inhibitory activities with [Formula: see text] values ranging from 10.50 to [Formula: see text]. Our structure-activity relationship analysis indicated that 2-thiazolylhydrazone is an effective scaffold for NA inhibitors and that introducing an ethoxycarbonyl group to the 5-position of thiazole ring could enhance inhibitory potency. Molecular docking was performed on the most active compounds 1p and 2c to provide more insight into their mechanism of interaction.

Entities:  

Keywords:  Molecular docking; Neuraminidase (NA) inhibitors; One-pot reaction; Thiazolylhydrazones

Mesh:

Substances:

Year:  2017        PMID: 28536876     DOI: 10.1007/s11030-017-9740-0

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  23 in total

1.  Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.

Authors: 
Journal:  Lancet       Date:  1998-12-12       Impact factor: 79.321

Review 2.  Shifting from the single to the multitarget paradigm in drug discovery.

Authors:  José L Medina-Franco; Marc A Giulianotti; Gregory S Welmaker; Richard A Houghten
Journal:  Drug Discov Today       Date:  2013-01-20       Impact factor: 7.851

3.  Predicting dual-targeting anti-influenza agents using multi-models.

Authors:  Yu Wang; Hu Ge; Yali Li; Yufang Xie; Yingyan He; Mengyan Xu; Qiong Gu; Jun Xu
Journal:  Mol Divers       Date:  2014-10-02       Impact factor: 2.943

4.  Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: the prediction accuracy of sampling power and scoring power.

Authors:  Zhe Wang; Huiyong Sun; Xiaojun Yao; Dan Li; Lei Xu; Youyong Li; Sheng Tian; Tingjun Hou
Journal:  Phys Chem Chem Phys       Date:  2016-04-25       Impact factor: 3.676

5.  Synthesis and anti-influenza activity of aminoalkyl rupestonates.

Authors:  Jiangyu Zhao; Haji Akber Aisa
Journal:  Bioorg Med Chem Lett       Date:  2012-01-28       Impact factor: 2.823

6.  Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores.

Authors:  G T Wang; Y Chen; S Wang; R Gentles; T Sowin; W Kati; S Muchmore; V Giranda; K Stewart; H Sham; D Kempf; W G Laver
Journal:  J Med Chem       Date:  2001-04-12       Impact factor: 7.446

7.  LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions.

Authors:  A C Wallace; R A Laskowski; J M Thornton
Journal:  Protein Eng       Date:  1995-02

8.  Discovery of tyrosine kinase inhibitors by docking into an inactive kinase conformation generated by molecular dynamics.

Authors:  Hongtao Zhao; Danzhi Huang; Amedeo Caflisch
Journal:  ChemMedChem       Date:  2012-09-13       Impact factor: 3.466

Review 9.  Oseltamivir for control of influenza at mass gatherings.

Authors:  Mohamed Tashani; Harunor Rashid; Iman Ridda; Leon Heron; Ziad A Memish; Elizabeth Haworth; Robert Booy
Journal:  Infect Disord Drug Targets       Date:  2013-02

10.  On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).

Authors:  Petar M Mitrasinovic
Journal:  Biophys Chem       Date:  2008-11-20       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.